Telomerase gene therapy ameliorates the effects of neurodegeneration associated to short telomeres in mice AGING of Immune System Sex-specific components […]

CARBAMYLATION-derived products: bioactive compounds and potential biomarkers in chronic renal failure and atherosclerosis CARBAMYLATION and antibodies against carbamylated proteins in

  COGNITIVE ENHANCEMENT COGNITIVE ENHANCEMENT: methods, ethics, regulatory challenges COGNITIVE ENHANCEMENT as a treatment for drug addictions Neuroethical issues in

BRAIN metabolism during FASTING Caloric restriction and intermittent FASTING: two potential diets for successful BRAIN aging FASTING is neuroprotective following

PROTEIN CARBONYLATION PROTEIN CARBONYLATION in human diseases PROTEIN CARBONYLATION, cellular dysfunction, and disease progression Cell signaling by PROTEIN CARBONYLATION and

ANTI‐GLYCATIVE and ANTI‐inflammatory effects of caffeic acid and ellagic acid in kidney of diabetic mice ANTI-oxidative, ANTI–GLYCATIVE and ANTI-apoptotic effects

EXTRACELLULAR GLYCATION crosslinks: prospects for removal Attenuation of EXTRACELLULAR MATRIX accumulation in diabetic nephropathy by the advanced GLYCATION end product

GLYCATION and diabetic complications Role of GLYCATION in aging Mechanisms of GLYCATION in atherogenesis The pathological implications of protein GLYCATION.

The HPA axis is involved in the neurobiology of mood disorders and functional illnesses, including anxiety disorder, bipolar disorder, insomnia,